Search Results - "Kuwabara, Saki"
-
1
Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?
Published in Endocrine Journal (2022)“…Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are well-established means of improving glycemia and preventing cardio-renal events in patients with type 2…”
Get full text
Journal Article -
2
Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study
Published in Journal of diabetes research (19-01-2022)“…Incretins reduce glycemic variability (GV) in patients with type 2 diabetes, but it is unknown whether switching from a combination of basal insulin and a…”
Get full text
Journal Article -
3
Porphyromonas pogonae sp. nov., an anaerobic but low concentration oxygen adapted coccobacillus isolated from lizards (Pogona vitticeps) or human clinical specimens, and emended description of the genus Porphyromonas Shah and Collins 1988
Published in Systematic and applied microbiology (01-03-2015)“…During the process of identifying a Gram-negative coccobacillus isolated from a human clinical specimen, we found that the isolate's 16S rRNA gene had very…”
Get full text
Journal Article -
4
Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis
Published in Annals of the rheumatic diseases (01-08-2020)Get more information
Journal Article -
5
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas
Published in Pituitary (01-10-2023)“…Purpose Cushing’s disease (CD) results from autonomous adrenocorticotropic hormone (ACTH) secretion by corticotroph adenomas, leading to excessive cortisol…”
Get full text
Journal Article -
6
6376 Wnt/beta-catenin Pathway is Associated with Cell Proliferation in Growth Hormone-producing Pituitary Tumors
Published in Journal of the Endocrine Society (05-10-2024)“…Disclosure: S. Kuwabara: None. H. Kameda: None. H. Nomoto: None. K. Cho: None. A. Nakamura: None. Y. Ishi: None. H. Motegi: None. M. Fujimura: None. T. Atsumi:…”
Get full text
Journal Article -
7
THU044 The Subcellular Localization Of β-Catenin Is Associated With Tumor Size And The Surgical Remission Rate In Growth Hormone-producing Pituitary Adenomas
Published in Journal of the Endocrine Society (05-10-2023)“…Disclosure: S. Kuwabara: None. H. Kameda: None. H. Nomoto: None. K. Cho: None. A. Nakamura: None. Y. Ishi: None. H. Motegi: None. F. Miki: None. H. Miyoshi:…”
Get full text
Journal Article -
8
Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?
Published in Endocrine Journal (2021)“…Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are well-established means of improving glycemia and preventing cardio-renal events in patients with type 2…”
Get full text
Journal Article -
9
-
10
ODP190 Efficacy of Esaxerenone on Hypertensive Patients with Type 2 Diabetes or Those with Impaired Glucose Tolerance
Published in Journal of the Endocrine Society (01-11-2022)“…Patients with diabetes may develop mineralocorticoid receptor (MR) related hypertension due to abnormal activation of MR, thusMR blocker (MRB) is used for the…”
Get full text
Journal Article